AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 21 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,630,000 | +1304.9% | 14,068,000 | +1123.3% | 2.74% | +684.3% |
| Q2 2020 | $899,000 | +2.4% | 1,150,000 | 0.0% | 0.35% | -29.7% |
| Q1 2020 | $878,000 | -91.2% | 1,150,000 | -90.3% | 0.50% | -90.1% |
| Q4 2019 | $10,012,000 | +29.5% | 11,900,000 | +26.6% | 5.02% | +14.5% |
| Q3 2019 | $7,732,000 | -15.5% | 9,400,000 | -17.5% | 4.38% | -17.5% |
| Q2 2019 | $9,153,000 | +6.0% | 11,400,000 | +15.2% | 5.31% | +0.8% |
| Q1 2019 | $8,638,000 | +7.1% | 9,900,000 | +12.5% | 5.27% | +15.6% |
| Q4 2018 | $8,067,000 | -12.2% | 8,800,000 | 0.0% | 4.56% | -14.7% |
| Q3 2018 | $9,187,000 | +2.0% | 8,800,000 | 0.0% | 5.34% | -31.0% |
| Q2 2018 | $9,006,000 | +15.4% | 8,800,000 | +16.6% | 7.74% | +36.7% |
| Q1 2018 | $7,804,000 | +71.9% | 7,550,000 | +43.8% | 5.66% | +110.0% |
| Q4 2017 | $4,540,000 | +33.3% | 5,250,000 | +50.0% | 2.70% | +18.4% |
| Q3 2017 | $3,405,000 | +252.8% | 3,500,000 | +250.0% | 2.28% | +232.1% |
| Q2 2017 | $965,000 | – | 1,000,000 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
| Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
| Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
| Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
| City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |